Glucocorticoid-Induced Osteoporosis
The use of glucocorticoids (GC) in the medium and long term, causes several considerable side effects, being one of the main ones the reduction of bone mineral density (BMD). Prolonged corticosteroid therapy reduces BMD by up to 20% in trabecular bone and approximately 2–3% in cortical bone in the f...
Guardado en:
| Autores principales: | , |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2021
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/76351 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares: Glucocorticoid-Induced Osteoporosis
- Mechanism of Glucocorticoid-Induced Osteoporosis: An Update
- Assessment of Glucocorticoids ‒ Induced Preclinical Atherosclerosis
- Glucocorticoid-Induced Cardioprotection: A Novel Role for Autophagy
- Molecular Mechanisms Conferring Resistance/Sensitivity to Glucocorticoid-Induced Apoptosis
- Non-GCs Drug-Induced Osteoporosis
- Regulation of Glucocorticoid Receptor Signaling and the Diabetogenic Effects of Glucocorticoid Excess